about
Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and PreventionThe relevance of HPA-15 antigen expression for anti-HPA-15 antibody detection.Recent advances in understanding the clinical relevance of antiplatelet alloantibodies.RHD variants in Polish blood donors routinely typed as D-Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?Introducing Pathogen Reduction Technology in Poland: A Cost-Utility AnalysisA preliminary evaluation of next-generation sequencing as a screening tool for targeted genotyping of erythrocyte and platelet antigens in blood donors.14 Years of Polish Experience in Non-Invasive Prenatal Blood Group DiagnosisRepertoire cloning of a human IgG inhibitor of alpha IIB beta 3 function. The OG idiotype.Compound heterozygosity of two novel RHAG alleles leads to a considerable disruption of the Rh complex.What weighs more-low compliance with self-deferral or minor medical procedures? Explaining the high rate of hepatitis C virus window-period donations in Poland.Real-Time PCR Analysis of Chimerism in T Cell Subsets as an Early Predictor of Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation.Molecular screening of the Cw antigen for typing donors compatible with patients with anti-MAR-like antibodies.Infectivity of blood products from donors with occult hepatitis B virus infection.Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.Incidence and treatment of hepatitis C virus infection in children with haemophilia in Poland.Analysis of hepatitis G virus infection markers in blood donors and patients with hepatitis.Sequence analysis confirmation of transfusion-transmitted hepatitis C by red blood cells that tested negative by minipool hepatitis C virus nucleic acid testing.Polymorphism of the TT virus and its frequency in Polish blood donors.International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.Effectiveness of various minipool nucleic acid test systems for hepatitis B virus detection in blood donors.Preliminary results of HBV DNA testing of Polish haemophilia patients--lack of occult HBV infection.Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland.Hepatitis C core antigen in Polish blood donors.Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.FUT1 mutations responsible for the H-deficient phenotype in the Polish population, including the first example of an abolished start codon.Measures to prevent transfusion-related acute lung injury (TRALI).Lysophosphatidylcholines: bioactive lipids generated during storage of blood components.Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation.Analysis of leucocyte antibodies, cytokines, lysophospholipids and cell microparticles in blood components implicated in post-transfusion reactions with dyspnoea.Preliminary results of fetal Rhc examination in plasma of pregnant women with anti-c.Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma.Single nucleotide polymorphisms in A4GALT spur extra products of the human Gb3/CD77 synthase and underlie the P1PK blood group system.Logistics of platelet concentratesesBiobanks of blood from donors and recipients of blood productsCorrelation of monocyte-monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than DMonocyte-erythrocyte interaction in autoimmune haemolytic anaemia in relation to the number of erythrocyte-bound IgG molecules and subclass specificity of autoantibodiesAbility of monoclonal anti-D antibodies to promote the binding of red cells to lymphocytes, granulocytes and monocytesAn in-vitro assessment of the functional activity of monoclonal anti-DSerological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn
P50
Q26777281-B546A07B-7672-4192-B7B5-AF4E5050A4C3Q33396238-64DDCF1E-FE9C-49AD-86DC-0A35EC2D9CC5Q33440683-A97F6D4A-38BB-4A05-9F5A-366E2969465DQ33873433-EF227D39-9595-4B14-8C07-651364BE6934Q34722826-0268D11D-4254-426E-B308-AB5CE50AA14CQ35789569-7FF78DD2-A5C9-47CA-B611-BC954570BDD2Q36305936-C012E77B-CB2A-4CEB-8040-F7D38D349EC1Q36423067-286BD751-792F-4ABE-B4AE-2306CBEDEE42Q36679310-718B2DA6-589F-4D5C-8772-440C1F20F331Q39850492-524C3DC9-A407-4407-81D5-B7AC8E20D901Q40181372-AC6B1AA0-8B11-424B-951A-2A496FA05B74Q41076868-13D1C70C-D561-4565-9367-1BA5593A5B50Q42100421-77FE0BA5-8743-4E9D-90C4-39DC268B0684Q42277057-56186F02-2628-414F-A073-E9D591BE0FF0Q42991247-07EE5851-2AA9-438E-9DEA-591F72BCE2A1Q42996232-9E4CFC31-E48E-46C2-A32C-705F4B987A6FQ42996632-E0EB5F11-869B-4737-9A54-8802660842F5Q43037968-5A689BAF-695F-450D-A1EA-17612CC8325AQ43405361-196C02AB-1C58-4575-AA94-61E9C4570AA4Q44626193-DE672B90-22C8-464F-B5AB-673EC049C866Q45382811-8BE8E4CE-CB8C-46D8-85DE-F81DCED7FB89Q45859628-738E6D44-8EDA-4754-B728-246BD1714395Q46075390-2A6E694B-4BBD-4442-8C33-FDB37401A70CQ47269593-FD6FCB6D-3A24-4216-811F-3EE7E3FD6B04Q48061528-32EFAA24-3F70-4109-8A3B-6973593D20DCQ49300785-494EE126-21FA-48A7-8F31-D9A75A122520Q50498728-E9F56136-C50A-4DC6-B2C9-7A6BBBBD177BQ50520711-044E5342-709A-4246-88CC-36403814DE05Q50777447-BB21C586-A1C2-408B-A265-BE18AB3163CAQ51703191-16222375-66DD-4F82-9E5D-E1088B442E7BQ54539332-1E87163D-8A16-4632-9A8B-6CB6FFBE1A8DQ54646324-FD728C95-EFA6-48FA-B861-F5D1F8F01017Q55047205-35A2C700-FFD3-40B1-8441-C998258C1850Q60213171-5DDDAD0C-0D13-429E-BC86-E164F6366FE9Q61718851-4A5F0942-8A95-44CA-9B59-646B3AA678BBQ68918462-222C9149-36B4-4706-941E-7015B98C8CC5Q69099834-9F5C51CC-8814-4C5F-B5B4-DBF5EEFB1CF5Q69176665-0917F5B1-B4C7-4161-9002-B45B02D440F3Q69189968-C5E7D0FA-E76C-4FD3-A376-209FEFF444DFQ69222573-8DDDEF1B-6190-4631-BBE1-4A819A8CBD3C
P50
description
researcher ORCID ID = 0000-0003-1947-6888
@en
wetenschapper
@nl
name
E Brojer
@ast
E Brojer
@en
E Brojer
@es
E Brojer
@nl
type
label
E Brojer
@ast
E Brojer
@en
E Brojer
@es
E Brojer
@nl
prefLabel
E Brojer
@ast
E Brojer
@en
E Brojer
@es
E Brojer
@nl
P214
P1153
57191484062
P214
P31
P496
0000-0003-1947-6888
P7859
viaf-101775198